Egypt Cluster
EVA Pharma’s legacy dates back to 1917, it emerged as a leading pharmaceutical company through innovation and dedication to quality. Currently, EVA Pharma has rapidly expanded its product portfolio to 300+ products and 500+ products in pipeline as well as its global presence in 40+ countries while maintaining high standards of safety and efficacy. Today, it remains a key player in Egypt's healthcare industry, impacting millions of lives with its products and initiatives.
#1
1st in the Egyptian Pharmaceutical Industry
#4
Internationally Accredited Manufacturing Sites
300+
Products in Portfolio
500+
Products in pipeline
Excellence in Regulatory Affairs
EVA Pharma's unparalleled expertise in Regulatory Affairs is evident when we compare our achievements to industry standards. In the Egypt Cluster, where regulatory success is pivotal, EVA Pharma stands out significantly where we registered for our partners almost 41 small molecules and 18 biologicals successfully and other products are under registration.
41 Small molecules
18 biologicals
Thanks for your interest in EVA Pharma
Fill up the form and our team will get back to you shortly
Follow Us
